遼寧成大(600739.SH):董事會通過關於成大生物附條件生效的向股轉系統申請終止掛牌
格隆匯 9 月 7日丨遼寧成大(600739.SH)公佈,公司第九屆董事會第二十二次(臨時)會議決議,審議通過關於公司所屬子公司附條件生效的向全國中小企業股份轉讓系統申請終止掛牌的議案;
公司所屬子公司遼寧成大生物股份有限公司(“成大生物”)擬首次公開發行人民幣普通股(A股)股票並在科創板上市。此次發行上市申請已獲得上海證券交易所的正式受理,尚需取得上海證券交易所的審核同意以及中國證券監督管理委員會同意註冊的決定。
公司董事會同意成大生物在本次發行上市的申請通過上海證券交易所上市委員會審核後,擇機向全國中小企業股份轉讓系統有限責任公司申請其股票在全國中小企業股份轉讓系統終止掛牌。成大生物申請其股票終止掛牌事宜尚需提交成大生物股東大會審議,在審議通過後將在成大生物本次發行上市的申請通過上海證券交易所上市委員會審議後擇機予以實施,且需經全國中小企業股份轉讓系統有限責任公司的審核批准。
成大生物申請其股票終止掛牌事宜以及成大生物本次發行上市均存在不確定性,敬請廣大投資者注意投資風險。
另外審議通過關於公司所屬子公司股票在全國中小企業股份轉讓系統終止掛牌異議股東保護措施的議案;
公司所屬子公司成大生物擬在首次公開發行人民幣普通股(A股)股票並在科創板上市的申請通過上海證券交易所上市委員會審核後,擇機申請股票在全國中小企業股份轉讓系統(“股轉系統”)終止掛牌,為充分保護可能存在的成大生物異議股東的權益,公司作為成大生物控股股東,同意與異議股東進行洽談,對異議股東持有的成大生物股份進行回購。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.